The long-term goal of this project is to identify clinical and genetic features of retinopathy of prematurity (ROP) development, and to analyze their relationships. Although biomedical research data are being generated at an enormous pace, much less work has been done to integrate disparate scientific findings across the spectrum from genomics to imaging to clinical medicine. Our overall hypotheses are that genetic factors are involved in the initiation and modulation of ROP pathogenesis, and that there are etiological relationships among clinical, imaging, and genetic findings in ROP. These hypotheses will be tested using two sequential Specific Aims: (1) Recruit, phenotype, and collect genetic material from a cohort of over 1460 premature infants at- risk for ROP from 7 study centers. Data will be stored in a web-based data management system that will be developed for this project. Demographic and clinical features from three serial ophthalmoscopic examinations will be ascertained fully, and serial wide- angle images will be captured. DNA will be isolated and prepared for genotyping. (2) Quantify retinal vascular features using computer-based image analysis, and analyze relationships between clinical and image findings in ROP. Models for integrating the effects of quantitative image traits, clinical features, and environmental risk factors on ROP susceptibility will be estimated. Genotyping, genetic analysis, recruitment of additional subjects as needed, and modeling of clinical and genetic traits will be pursued during competitive renewal of this project. Ultimately, these studies should improve understanding of neovascularization in ROP and related ocular diseases, and of normal vascular development in infants. In addition, this work should demonstrate a prototype for health information management which combines genotypic and phenotypic data. This project will be performed by a multi-disciplinary team of collaborative investigators with expertise in clinical ophthalmology, biomedical informatics, genetic analysis, and statistical genetics.
ROP is a leading cause of childhood blindness in the United States and throughout the world, and the number of infants at risk for disease is increasing as the rate of premature birth rises. Rapidly-progressive changes associated with retinal vascular development and angiogenesis may be visualized by clinical examination, captured by wide-angle imaging, and analyzed genetically. Findings from this project should improve our understanding of the pathogenesis of ROP and other neovascular diseases, and provide better methods for identifying infants who are at highest risk of developing disease.
|Port, Alexander D; Chan, R V Paul; Ostmo, Susan et al. (2014) Risk factors for retinopathy of prematurity: insights from outlier infants. Graefes Arch Clin Exp Ophthalmol 252:1669-77|
|Sommer, Alfred; Taylor, Hugh R; Ravilla, Thulasiraj D et al. (2014) Challenges of ophthalmic care in the developing world. JAMA Ophthalmol 132:640-4|
|Guaiquil, Victor H; Hewing, Nina J; Chiang, Michael F et al. (2013) A murine model for retinopathy of prematurity identifies endothelial cell proliferation as a potential mechanism for plus disease. Invest Ophthalmol Vis Sci 54:5294-302|
|Keck, Katie M; Kalpathy-Cramer, Jayashree; Ataer-Cansizoglu, Esra et al. (2013) Plus disease diagnosis in retinopathy of prematurity: vascular tortuosity as a function of distance from optic disk. Retina 33:1700-7|
|Fierson, Walter M; American Academy of Pediatrics Section on Ophthalmology; American Academy of Ophthalmology et al. (2013) Screening examination of premature infants for retinopathy of prematurity. Pediatrics 131:189-95|
|Kang, Kai B; Orlin, Anton; Lee, Thomas C et al. (2013) The use of digital imaging in the identification of skip areas after laser treatment for retinopathy of prematurity and its implications for education and patient care. Retina 33:2162-9|
|Chiang, Michael F; Read-Brown, Sarah; Tu, Daniel C et al. (2013) Evaluation of electronic health record implementation in ophthalmology at an academic medical center (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc 111:70-92|
|Hewing, Nina Jasmin; Weskamp, Gisela; Vermaat, Joost et al. (2013) Intravitreal injection of TIMP3 or the EGFR inhibitor erlotinib offers protection from oxygen-induced retinopathy in mice. Invest Ophthalmol Vis Sci 54:864-70|
|Hewing, Nina J; Kaufman, David R; Chan, R V Paul et al. (2013) Plus disease in retinopathy of prematurity: qualitative analysis of diagnostic process by experts. JAMA Ophthalmol 131:1026-32|
|Wong, Ryan K; Ventura, Camila V; Espiritu, Michael J et al. (2012) Training fellows for retinopathy of prematurity care: a Web-based survey. J AAPOS 16:177-81|
Showing the most recent 10 out of 11 publications